{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:06:23Z","timestamp":1787501183504,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1477-7827-12-59","type":"journal-article","created":{"date-parts":[[2014,7,5]],"date-time":"2014-07-05T03:01:45Z","timestamp":1404529305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Predictive factors for recovery time in patients suffering from severe OHSS"],"prefix":"10.1186","volume":"12","author":[{"given":"Kazem","family":"Nouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens B","family":"Tempfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lenart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Windischbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Walch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Promberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,5]]},"reference":[{"key":"1231_CR1","first-page":"188","volume":"90","author":"ASRM","year":"2008","unstructured":"ASRM: Ovarian hyperstimulation syndrome. Fertil Steril. 2008, 90: 188-202.","journal-title":"Fertil Steril"},{"key":"1231_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S1472-6483(10)60042-9","volume":"19","author":"A Golan","year":"2009","unstructured":"Golan A, Weissman A: Symposium: update on prediction and management of OHSS. A modern classification of OHSS. Reprod Biomed Online. 2009, 19: 28-32.","journal-title":"Reprod Biomed Online"},{"key":"1231_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1477-7827-9-147","volume":"9","author":"EG Papanikolaou","year":"2011","unstructured":"Papanikolaou EG, Humaidan P, Polyzos N, Kalantaridou S, Kol S, Benadiva C, Tournaye H, Tarlatzis B: New algorithm for OHSS prevention. Reproductive biology and endocrinology. Reprod Biol Endocrinol. 2011, 9: 147-153.","journal-title":"Reprod Biol Endocrinol"},{"key":"1231_CR4","first-page":"11","volume":"52","author":"H Binder","year":"2007","unstructured":"Binder H, Dittrich R, Einhaus F, Krieg J, M\u00fcller A, Strauss R, Beckmann MW, Cupisti S: Update on ovarian hyperstimulation syndrome: Part 1\u2013Incidence and pathogenesis. Int J Fertil Womens Med. 2007, 52: 11-26.","journal-title":"Int J Fertil Womens Med"},{"key":"1231_CR5","first-page":"399","volume":"26","author":"XH Li","year":"2010","unstructured":"Li XH, Nowicka MA, Fritz-Rdzanek A, Grzybowski W, Walecka I, Niemiec KT, Jakimiuk AJ: C-reactive protein as the indicator of severity in ovarian hyperstimulation syndrome. Cyn Endo. 2010, 26: 399-403.","journal-title":"Cyn Endo"},{"key":"1231_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/humupd\/dmg005","volume":"9","author":"A Delvigne","year":"2003","unstructured":"Delvigne A, Rozenberg S: Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update. 2003, 9: 77-96.","journal-title":"Hum Reprod Update"},{"key":"1231_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1055\/s-0030-1265681","volume":"28","author":"M Aboulghar","year":"2010","unstructured":"Aboulghar M: Treatment of ovarian hyperstimulation syndrome. Semin Reprod Med. 2010, 28: 532-539.","journal-title":"Semin Reprod Med"},{"key":"1231_CR8","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0015-0282(16)60371-0","volume":"50","author":"A Golan","year":"1988","unstructured":"Golan A, Ron-El R, Herman A, Weinraub Z, Soffer Y, Caspi E: Ovarian hyper- stimulation syndrome following D-Trp-6 luteinizing hormone-releasing hormone microcapsules and menotropin for invitro fertilization. Fertil Steril. 1988, 50: 912-916.","journal-title":"Fertil Steril"},{"key":"1231_CR9","first-page":"592","volume":"18","author":"FIVNAT Bilan","year":"1989","unstructured":"Bilan FIVNAT: responses aux stimulation de L\u2019ovulation dans les procreations medicalement assistes (PMA). Contracept Fertil Sex. 1989, 18: 592-594.","journal-title":"Contracept Fertil Sex"},{"key":"1231_CR10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/oxfordjournals.humrep.a138597","volume":"9","author":"K Diedrich","year":"1994","unstructured":"Diedrich K, Diedrich C, Santos E, Zoll C, al-Hasani S, Reissmann T, Krebs D, Klingmuller D: Suppression of the endogenous LH-surge by the LH-RH antagonist Cetrorelix during ovarian stimulation. Hum Reprod. 1994, 9: 788-791.","journal-title":"Hum Reprod"},{"key":"1231_CR11","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/humrep\/17.4.874","volume":"17","author":"HG Al-Inany","year":"2002","unstructured":"Al-Inany HG, Aboulghar M: GnRH antagonists for assisted reproduction: a Cochrane review. Hum Reprod. 2002, 17: 874-885.","journal-title":"Hum Reprod"},{"key":"1231_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/humupd\/dml038","volume":"12","author":"EM Kolibianakis","year":"2006","unstructured":"Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G: Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update. 2006, 12: 651-671.","journal-title":"Hum Reprod Update"},{"key":"1231_CR13","first-page":"CD001750","volume":"19","author":"HG Al-Inany","year":"2006","unstructured":"Al-Inany HG, Abou-Setta AM, Aboulghar M: Gonadotrophin-releasing hormone antagonist for assisted conception. Cochrane Database Syst Rev. 2006, 19: CD001750-","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1231_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.fertnstert.2010.03.028","volume":"9","author":"P Humaidan","year":"2010","unstructured":"Humaidan P, Quartarolo J, Papanikolaou EG: Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril. 2010, 9 (4): 389-400.","journal-title":"Fertil Steril"},{"key":"1231_CR15","volume-title":"Am J Obstet Gynecol","author":"AP Bailey","year":"2014","unstructured":"Bailey AP, Hawkins LK, Missmer SA, Correia KF, Yanushpolsky EH: Effect of body mass index on in vitro fertilization outcomes in women with polycystic ovary syndrome. Am J Obstet Gynecol. 2014, [Epub ahead of print]"},{"key":"1231_CR16","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1210\/jc.2007-1250","volume":"92","author":"MA Aboulghar","year":"2007","unstructured":"Aboulghar MA: Preventing Ovarian Hyperstimulation Syndrome. J Clin Endocrin Metabol. 2007, 92: 2882-2884.","journal-title":"J Clin Endocrin Metabol"},{"key":"1231_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1477-7827-10-32","volume":"10","author":"K Fiedler","year":"2012","unstructured":"Fiedler K, Ezcurra D: Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol. 2012, 10: 32-","journal-title":"Reprod Biol Endocrinol"},{"key":"1231_CR18","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.fertnstert.2006.12.058","volume":"88","author":"EM Kolibianakis","year":"2007","unstructured":"Kolibianakis EM, Papanikolaou EG, Tournaye H, Camus M, Van Steirteghem AC, Devroey P: Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone. Fertil Steril. 2007, 88: 1382-1388.","journal-title":"Fertil Steril"},{"key":"1231_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1586\/eog.09.10","volume":"4","author":"B Ata","year":"2009","unstructured":"Ata B, Tulandi T: Pathophysiology of ovarian hyperstimulation syndrome and strategies for its prevention and treatment. Expert Rev Obstet Gynecol. 2009, 4: 299-311.","journal-title":"Expert Rev Obstet Gynecol"},{"key":"1231_CR20","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1093\/humrep\/det124","volume":"28","author":"A Seyhan","year":"2013","unstructured":"Seyhan A, Ata B, Polat M, Son WY, Yarali H, Dahan MH: Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG. Hum Reprod. 2013, 28: 2522-2528.","journal-title":"Hum Reprod"},{"key":"1231_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1210\/jcem.87.2.8197","volume":"87","author":"BC Fauser","year":"2002","unstructured":"Fauser BC, de Jong D, Olivennes F, Wramsby H, Tay C, Itskovitz-Eldor J, van Hooren HG: Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab. 2002, 87: 709-715.","journal-title":"J Clin Endocrinol Metab"},{"key":"1231_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1055\/s-0030-1265670","volume":"28","author":"R G\u00f3mez","year":"2010","unstructured":"G\u00f3mez R, Soares SR, Busso C, Garcia-Velasco JA, Sim\u00f3n C, Pellicer A: Physiology and pathology of ovarian hyperstimulation syndrome. Semin Reprod Med. 2010, 28: 448-457.","journal-title":"Semin Reprod Med"},{"key":"1231_CR23","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/humupd\/dmr025","volume":"17","author":"KA Toulis","year":"2011","unstructured":"Toulis KA, Goulis DG, Mintziori G, Kintiraki E, Eukarpidis E, Mouratoglou SA, Pavlaki A, Stergianos S, Poulasouchidou M, Tzellos TG, Makedos A, Chourdakis M, Tarlatzis BC: Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome. Hum Reprod Update. 2011, 17: 741-760.","journal-title":"Hum Reprod Update"},{"key":"1231_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejogrb.2009.11.017","volume":"149","author":"A Swanton","year":"2010","unstructured":"Swanton A, Storey L, McVeigh E, Child T: IVF outcome in women with PCOS, PCO and normal ovarian morphology. Eur J Obstet Gynecol Reprod Biol. 2010, 149: 68-71.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1231_CR25","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0015-0282(00)00492-1","volume":"73","author":"RS Mathur","year":"2000","unstructured":"Mathur RS, Akande AV, Keay SD, Hunt LP, Jenkins JM: Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril. 2000, 73: 901-907.","journal-title":"Fertil Steril"},{"key":"1231_CR26","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1093\/humrep\/deg302","volume":"18","author":"S Kol","year":"2003","unstructured":"Kol S: Prediction of ovarian hyperstimulation syndrome: why predict if we can prevent!. Hum Reprod. 2003, 18: 1557-1558.","journal-title":"Hum Reprod"},{"key":"1231_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/09513590.2012.730578","volume":"29","author":"T Kalampokas","year":"2013","unstructured":"Kalampokas T, Creatsas G, Kalampokas E: Cabergoline as treatment of ovarian hyperstimulation syndrome: a review. Gynecol Endocrinol. 2013, 29: 98-100.","journal-title":"Gynecol Endocrinol"},{"key":"1231_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/14647273.2013.833348","volume":"16","author":"M Baumgarten","year":"2013","unstructured":"Baumgarten M, Polanski L, Campbell B, Raine-Fenning N: Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis. Hum Fertil. 2013, 16: 168-174.","journal-title":"Hum Fertil"},{"key":"1231_CR29","first-page":"6","volume":"10","author":"MM Alper","year":"2009","unstructured":"Alper MM, Smith LP, Sills ES: Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management. J Exp Clin Assist Reprod. 2009, 10: 6-3","journal-title":"J Exp Clin Assist Reprod"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7827-12-59.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:54:25Z","timestamp":1630544065000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/1477-7827-12-59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1231"],"URL":"https:\/\/doi.org\/10.1186\/1477-7827-12-59","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,5]]},"assertion":[{"value":"21 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"59"}}